Best treatments for primary myelofibrosis
7 products may treat primary myelofibrosis, spanning FDA drug classes such as alkylating drug, janus kinase inhibitor, kinase inhibitor. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 7 drugs we list for primary myelofibrosis, none are yet flagged as generics in our price data, spanning classes such as alkylating drug, janus kinase inhibitor, kinase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for primary myelofibrosis — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Injectable | Alkylating Drug | No data | — | View → | |
| 2 | Not yet rated | Prescription | Capsule | — | No data | — | View → | |
| 3 | Not yet rated | Prescription | Tablet | Janus Kinase Inhibitor | No data | — | View → | |
| 4 | Not yet rated | Prescription | Tablet | Janus Kinase Inhibitor | No data | — | View → | |
| 5 | Not yet rated | Prescription | Tablet | Alkylating Drug | No data | — | View → | |
| 6 | Not yet rated | Prescription | Topical | Janus Kinase Inhibitor | No data | — | View → | |
| 7 | Not yet rated | Prescription | Capsule | Kinase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: janus kinase inhibitor · alkylating drug
Full ranking · 7 treatments
busulfex
PrescriptionFDA-sourced
Busulfex (Busulfan) is an alkylating drug used to treat Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis.
Price varies
inrebic
Boxed warningPrescriptionFDA-sourced
Inrebic (Fedratinib Hydrochloride) is a medication used to treat Primary Myelofibrosis.
Price varies
jakafi
PrescriptionFDA-sourced
Jakafi (Ruxolitinib Phosphate) is a janus kinase inhibitor used to treat Polycythemia Vera, Primary Myelofibrosis.
Price varies
jakafi xr
PrescriptionFDA-sourced
Jakafi XR (Ruxolitinib Phosphate) is a janus kinase inhibitor used to treat Polycythemia Vera, Primary Myelofibrosis.
Price varies
myleran
Boxed warningPrescriptionFDA-sourced
Myleran (Busulfan) is an alkylating drug used to treat Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis.
Price varies
opzelura
Boxed warningPrescriptionFDA-sourced
Opzelura (Ruxolitinib Phosphate) is a janus kinase inhibitor used to treat Polycythemia Vera, Primary Myelofibrosis.
Price varies
Frequently asked
- What treats primary myelofibrosis?
- Our catalog lists 7 products that may treat primary myelofibrosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
- What is the best-rated treatment for primary myelofibrosis?
- Ratings appear as FDA recall-safety data accumulates for the products that may treat primary myelofibrosis.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat primary myelofibrosis?
- Treatments for primary myelofibrosis span FDA drug classes including alkylating drug, janus kinase inhibitor, kinase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status